Washington, DC, (January 21, 2022) – FOCUS Investment Banking (“FOCUS”), a leading national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, is delighted to be acknowledged as #1 on Axial’s Top Lower Middle Market M&A Advisors list for Q4 2021. This marks the second consecutive quarter the firm has received this recognition.
The home health care and hospice industry is expected to continue its fast growth rate resulting in business owners reviewing when it may be the best time to sell.
The hospice and home health care industry is expected to grow strongly over the foreseeable future, driven by powerful demographic trends, including a rising elderly population, longer life spans and more chronic and age-related illnesses.
A must read for Home Healthcare and Hospice Agency Owners. We examine the key factors that have come together like a perfect storm to create the major industry consolidation currently underway. A unique window of opportunity now exists where eager buyers and motivated sellers can complete win/win deals.
Private equity firms and strategic investors are interested in acquiring agencies to expand their home healthcare and hospice businesses at the same time sellers are dealing with the operational challenges created by the recent shift to the Patient Driven Grouping Model. This has led to a record level of deal activity during the first eight months of 2021.
One of the most experienced middle market investment banking teams in the country
Welcome to the FOCUS Healthcare Group. Leveraging years of industry specific transaction experience, our bankers can confidently advise on mergers, acquisitions and raising capital for growing businesses across the Healthcare Industry.
All types of medical practices have been consolidating over the past 10+ years. While transaction volume declined in 2020 activity accelerated. 2021 will be a record year for completed transactions.
2021 projects that private equity investment in behavioral health will reach an all-time high as investors seek to cash in on the growing demand for therapeutic services.
The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.
